Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE | 4MG | TABLET | Resolved | 2021-07-16 | 2021-07-24 | 142683 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2021-09-03 | 2021-09-27 | 145153 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2021-10-29 | 2022-02-28 | 148509 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-02-04 | 2022-02-28 | 154184 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-03-04 | 2022-03-24 | 156036 |
APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2022-03-07 | 2022-07-15 | 156214 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-05-27 | 2022-08-11 | 161451 |
APO-GUANFACINE XR | 4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-22 | 2022-08-06 | 165322 |
APO-CANDESARTAN | 4MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166589 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-10-17 | 2022-11-20 | 171889 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2022-11-04 | 2022-12-05 | 173818 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2023-07-21 | 2024-03-01 | 199536 |
APO-HYDROMORPHONE | 4MG | TABLET | Resolved | 2023-09-07 | 2023-11-06 | 203852 |
APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2023-09-28 | 2023-10-15 | 205495 |
APO-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-12-08 | 2024-03-22 | 212946 |
APO-GUANFACINE XR | 4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-15 | 2024-01-12 | 213559 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-02-02 | 2024-03-08 | 218385 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-02-16 | 2024-03-08 | 219837 |
APO-OXYBUTYNIN | 5 MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 414 |
APO-MIDODRINE | 5.0MG | TABLET | Resolved | 2017-03-28 | 2017-04-14 | 4521 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 |